skip to content
Primary navigation


Drug Odomzo® (sonidegib) [Novartis]

March 2016

Therapeutic area - Basal cell carcinoma

Approval criteria

  • Patient is 18 years of age or older AND
  • Provider must:
    • Verify the pregnancy status of female patient OR
    • Advise the risk of exposure of male patient
  • Patient has a diagnosis of basal cell carcinoma AND one of the following:
    • Disease has recurred after surgery or radiation OR
    • Patient is not a candidate for surgery or radiation

Quantity limit

Maximum of 34 capsules per 34 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top